Literature DB >> 11375986

Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog.

E M Leslie1, K Ito , P Upadhyaya, S S Hecht, R G Deeley, S P Cole.   

Abstract

Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) play a crucial role in the induction of lung cancer, and NNAL-O-glucuronide formation and elimination are important steps in detoxification of these compounds. In the present study, we investigated the ATP-binding cassette (ABC) protein, MRP1 (ABCC1), as a candidate transporter responsible for NNAL-O-glucuronide export. MRP1 mediates the active transport of numerous GSH-, sulfate-, and glucuronide-conjugated organic anions and can transport certain xenobiotics by a mechanism that may involve co-transport with GSH. Using membrane vesicles prepared from transfected cells, we found that MRP1 transports [3H]NNAL-O-glucuronide but is dependent on the presence of GSH (Km 39 microm, Vmax 48 pmol x mg(-1) x min(-1)). We also found that the sulfur atom in GSH was dispensable because transport was supported by the GSH analog, gamma-glutamyl-alpha-aminobutyryl-glycine. Despite stimulation of NNAL-O-glucuronide transport by GSH, there was no detectable reciprocal stimulation of [3H]GSH transport. Moreover, whereas the MRP1 substrates leukotriene C4 (LTC4) and 17beta-estradiol 17beta-(d-glucuronide) (E(2)17betaG) inhibited GSH-dependent uptake of [3H]NNAL-O-glucuronide, only [3H]LTC4 transport was inhibited by NNAL-O-glucuronide (+GSH) and the kinetics of inhibition were complex. A mutant form of MRP1, which transports LTC4 but not E(2)17betaG, also did not transport NNAL-O-glucuronide suggesting a commonality in the binding elements for these two glucuronidated substrates, despite their lack of reciprocal transport inhibition. Finally, the related MRP2 transported NNAL-O-glucuronide with higher efficiency than MRP1 and unexpectedly, GSH inhibited rather than stimulated uptake. These studies provide further insight into the complex interactions of the MRP-related proteins with GSH and their conjugated organic anion substrates, and extend the range of xenotoxins transported by MRP1 and MRP2 to include metabolites of known carcinogens involved in the etiology of lung and other cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375986     DOI: 10.1074/jbc.M102453200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues.

Authors:  Liqi Lai; Theresa M C Tan
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 2.  The role of diet on the clinical pharmacology of oral antineoplastic agents.

Authors:  Antonio Ruggiero; Maria G Cefalo; Paola Coccia; Stefano Mastrangelo; Palma Maurizi; Riccardo Riccardi
Journal:  Eur J Clin Pharmacol       Date:  2011-07-28       Impact factor: 2.953

3.  Role of the NH2-terminal membrane spanning domain of multidrug resistance protein 1/ABCC1 in protein processing and trafficking.

Authors:  Christopher J Westlake; Susan P C Cole; Roger G Deeley
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

4.  Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients.

Authors:  Margaretha van der Deen; Hendrik Marks; Brigitte W M Willemse; Dirkje S Postma; Michael Müller; Egbert F Smit; George L Scheffer; Rik J Scheper; Elisabeth G E de Vries; Wim Timens
Journal:  Virchows Arch       Date:  2006-10-27       Impact factor: 4.064

5.  Tobacco carcinogen NNK transporter MRP2 regulates CFTR function in lung epithelia: implications for lung cancer.

Authors:  Chunying Li; John D Schuetz; Anjaparavanda P Naren
Journal:  Cancer Lett       Date:  2010-01-20       Impact factor: 8.679

6.  Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.

Authors:  Helen H W Chen; Macus Tien Kuo
Journal:  Met Based Drugs       Date:  2010-09-14

7.  Localization of the GSH-dependent photolabelling site of an agosterol A analog on human MRP1.

Authors:  Xiao-Qin Ren; Tatsuhiko Furukawa; Shunji Aoki; Tomoyuki Sumizawa; Misako Haraguchi; Xiao-Fang Che; Motomasa Kobayashi; Shin-ichi Akiyama
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 8.  Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology.

Authors:  Nazzareno Ballatori; Suzanne M Krance; Rosemarie Marchan; Christine L Hammond
Journal:  Mol Aspects Med       Date:  2008-08-26

Review 9.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

10.  Pulmonary metabolism of resveratrol: in vitro and in vivo evidence.

Authors:  Satish Sharan; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2013-03-08       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.